QRG Capital Management Inc. lifted its holdings in Cigna Group (NYSE:CI - Free Report) by 35.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,694 shares of the health services provider's stock after acquiring an additional 5,902 shares during the period. QRG Capital Management Inc.'s holdings in Cigna Group were worth $6,256,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of CI. Evercore Wealth Management LLC grew its position in shares of Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider's stock worth $347,000 after purchasing an additional 35 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in shares of Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider's stock valued at $100,000 after buying an additional 36 shares during the period. Independence Bank of Kentucky boosted its stake in shares of Cigna Group by 2.6% in the second quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider's stock valued at $409,000 after buying an additional 37 shares during the period. West Family Investments Inc. grew its position in Cigna Group by 4.2% during the second quarter. West Family Investments Inc. now owns 919 shares of the health services provider's stock worth $253,000 after buying an additional 37 shares in the last quarter. Finally, Whetstone Capital Advisors LLC grew its position in Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider's stock worth $228,000 after buying an additional 39 shares in the last quarter. 86.99% of the stock is owned by institutional investors.
Cigna Group Stock Performance
NYSE CI opened at $265.54 on Friday. The firm's fifty day moving average price is $280.52 and its two-hundred day moving average price is $280.32. The stock has a market cap of $70.16 billion, a PE ratio of 10.99, a PEG ratio of 0.94 and a beta of 0.31. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.
Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group's revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, September 8th. Cigna Group's dividend payout ratio (DPR) is presently 25.82%.
Insider Transactions at Cigna Group
In related news, insider Nicole S. Jones sold 2,677 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 22,730 shares of company stock worth $6,293,359 over the last three months. Insiders own 0.60% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have weighed in on CI shares. Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 price objective for the company. Wolfe Research reissued an "outperform" rating and set a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Jefferies Financial Group cut Cigna Group from a "buy" rating to a "hold" rating and decreased their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Guggenheim boosted their price target on Cigna Group from $338.00 to $361.00 and gave the company a "buy" rating in a research note on Friday, July 31st. Finally, Raymond James Financial downgraded shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and reduced their price objective for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Fifteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $337.10.
Read Our Latest Research Report on CI
Cigna Group Profile
(
Free Report)
The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.
Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.